-
Oct 30, 2024
The Biden-Harris administration has stifled innovation and made it harder for new drugs to reach patients, write Vrushab Gowda and Brian J. Miller.
-
Apr 12, 2024
Despite over a decade of policy promises, patients still face myriad paper forms and PDFs while doctors spend up to 87 percent of their day typing. Care remains expensive,...
-
Mar 13, 2024
With the Biden administration focus on implementing the Inflation Reduction Act (IRA), developers of small molecule drugs face an uncertain future.
-
Mar 12, 2024
With the Biden administration focus on implementing the Inflation Reduction Act (IRA), developers of small molecule drugs face an uncertain future.
Oct 30, 2024The Biden-Harris administration has stifled innovation and made it harder for new drugs to reach patients, write Vrushab Gowda and Brian J. Miller.
Apr 12, 2024Despite over a decade of policy promises, patients still face myriad paper forms and PDFs while doctors spend up to 87 percent of their day typing. Care remains expensive,...
Mar 13, 2024With the Biden administration focus on implementing the Inflation Reduction Act (IRA), developers of small molecule drugs face an uncertain future. 